However, as initially observed in a subset of breast cancers [51] and here in most insensitive MPM cell lines, 15% of MPM tumours were highly proliferative despite the lack of CDK4 phosphorylation and thus are expected to be intrinsically resistant to CDK4/6i. This evidence concerns the gene CDK4 and breast cancer.